These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 25767072)

  • 41. Cutaneous lupus erythematosus: recent lessons from animal models.
    Ghoreishi M; Dutz JP
    Lupus; 2010 Aug; 19(9):1029-35. PubMed ID: 20693196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
    Fetter T; Smith P; Guel T; Braegelmann C; Bieber T; Wenzel J
    Front Immunol; 2020; 11():344. PubMed ID: 32194562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral lesions in lupus erythematosus-cytokines profiles of inflammatory infiltrate.
    Marques ER; Lourenço SV; Lima DM; Nico MM
    J Cutan Pathol; 2010 Apr; 37(4):439-45. PubMed ID: 19751227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
    Cho YM; Furie R
    Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current concepts of photosensitivity in cutaneous lupus erythematosus.
    Klein B; Kunz M
    Front Med (Lausanne); 2022; 9():939594. PubMed ID: 36091671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenesis of Skin Injury of Systemic Lupus Erythematosus.
    Deng GM
    Curr Rheumatol Rep; 2018 Feb; 20(2):5. PubMed ID: 29464447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apoptosis of keratinocytes and serum DNase I activity in patients with cutaneous lupus erythematosus: relationship with clinical and immunoserological parameters.
    Skiljevic D; Bonaci-Nikolic B; Brasanac D; Nikolic M
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):523-529. PubMed ID: 27557471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
    Patel J; Borucki R; Werth VP
    Curr Rheumatol Rep; 2020 Aug; 22(10):69. PubMed ID: 32845411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Update on the Pathogenesis of Skin Damage in Lupus.
    Li Q; Wu H; Zhou S; Zhao M; Lu Q
    Curr Rheumatol Rep; 2020 May; 22(5):16. PubMed ID: 32399815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathophysiology of cutaneous lupus erythematosus.
    Achtman JC; Werth VP
    Arthritis Res Ther; 2015 Aug; 17(1):182. PubMed ID: 26257198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
    Braunstein I; Klein R; Okawa J; Werth VP
    Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
    Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
    Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-33/ST2 Activation Is involved in Ro60-Regulated Photosensitivity in Cutaneous Lupus Erythematosus.
    Song Y; Wei F; Liu Y; Han F; Ma L; Zhuang Y; Pan C; Jia Z; Gong A
    Mediators Inflamm; 2022; 2022():4955761. PubMed ID: 35909659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The deposition of anti-DNA IgG contributes to the development of cutaneous lupus erythematosus.
    Dong Y; Zhang Y; Xia L; Wang P; Chen J; Xu M; Liu X; Xia Y
    Immunol Lett; 2017 Nov; 191():1-9. PubMed ID: 28899632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients.
    Braegelmann C; Hölzel M; Ludbrook V; Dickson M; Turan N; Ferring-Schmitt S; Sternberg S; Bieber T; Kuhn A; Wenzel J
    Exp Dermatol; 2016 May; 25(5):375-9. PubMed ID: 26910509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of soluble and cell surface molecules in the pathogenesis of autoimmune skin diseases.
    Drosera M; Facchetti F; Landolfo S; Mondini M; Nyberg F; Parodi A; Santoro A; Zampieri S; Doria A
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S7-13. PubMed ID: 16466628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray.
    Toberer F; Sykora J; Göttel D; Hartschuh W; Werchau S; Enk A; Joos S; Krammer PH; Kuhn A
    Exp Dermatol; 2013 Oct; 22(10):656-9. PubMed ID: 24079735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical manifestations of cutaneous lupus erythematosus.
    Kuhn A; Sticherling M; Bonsmann G
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1124-37. PubMed ID: 18042093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ultraviolet radiation in the pathogenesis of lupus erythematosus].
    Kurz B; Klein B; Berneburg M; Meller S
    Dermatologie (Heidelb); 2024 Jul; 75(7):528-538. PubMed ID: 38916603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in the management of UVR-associated skin cancers: autoimmune diseases and UV protection.
    Lee HI; Worm M
    Br J Dermatol; 2009 Nov; 161 Suppl 3():96-8. PubMed ID: 19775364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.